本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Apellis Pharmaceuticals Inc.

17.33
-0.3150-1.79%
成交量:29.19萬
成交額:505.11萬
市值:22.15億
市盈率:100.49
高:17.61
開:17.55
低:17.08
收:17.64
52周最高:30.48
52周最低:16.10
股本:1.28億
流通股本:7,811.99萬
量比:0.28
換手率:0.37%
股息:- -
股息率:- -
每股收益(TTM):0.1724
每股收益(LYR):0.1724
淨資產收益率:7.48%
總資產收益率:3.53%
市淨率:5.98
市盈率(LYR):100.49

資料載入中...

2025/01/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities